NCT05918913 2025-09-05Expanded Access Program for RevumenibSyndax PharmaceuticalsNo longer available3 FDA
NCT05392374 2022-05-26Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine GliomasJazz PharmaceuticalsNo longer available3 FDA
NCT03134131 2022-03-14Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade GliomasJazz PharmaceuticalsNo longer available3 FDA